Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

6 Nov 2014 07:00

RNS Number : 2805W
Wilmington Group Plc
06 November 2014
 



6 November 2014

 

Wilmington Group plc

 

Interim Management Statement

 

 

Wilmington Group plc ("Wilmington" or "the Group"), the provider of Information, Compliance and Education to professional markets, presents its Interim Management Statement for the period from 1 July 2014, based on the results for the three months ended 30 September 2014 with comments reflecting trading to date. This statement is also being made at the Group's Annual General Meeting being held today.

 

Trading Update

 

The Group has made a good start to the year with revenue up during the three months ended 30 September 2014 despite adverse currency effects. Our business is performing well against the comparative period in 2013 and in line with our expectations.

 

Banking & Compliance: ICT (compliance training) continues to secure major training programmes from international banks, and this has resulted in strong revenue growth during the three months ended 30 September 2014. As previously reported we have invested in additional resource to support the business' expansion, and despite this contribution to profits has grown strongly. AMT (banking training) which delivers most of its revenue and contribution during the summer months has again delivered revenue and contribution in line with our expectations, with a particularly strong performance from its graduate programmes in Hong Kong. This division does have significant international operations and has been adversely impacted by movements in exchange rates.

 

Pensions & Insurance: This division continues to deliver revenue and contribution growth and has maintained its high margins. ICP (company credit reporting), which had a record year last year, has seen a small fall in demand but has mitigated this to a large extent by good cost control. This division also has significant international operations and has therefore also been adversely impacted by movements in exchange rates year on year.

 

Healthcare: This division benefitted from a significant investment last year with five senior appointments which is reflected in a higher overhead base in the first quarter compared to the same period in 2013. We have seen positive overall revenue growth compared to the same period in the prior year despite the negative impact of the Euro on our French language medical news agency, Agence de Presse Médicale. It is too early to see if the challenging conditions have abated but we are encouraged by the good start to the year.

 

Legal: The Legal division has continued to experience challenging conditions although the rate of decline has moderated and some areas, particularly Bond Solon, continue to see growth. Our lower cost base has meant that the performance from the division has improved compared to the same period in 2013.

 

Business Intelligence: As anticipated, revenue is up slightly on the same period in 2013. This combined with a lower cost base resulted in contribution in line with our expectations and up on the same period in 2013.

 

Accountancy: The division has enjoyed a strong start to the year reflecting inter alia demand for face to face public course training. This additional revenue is reflected in the division's pleasing overall increase in contribution due to the operational gearing of the business.

 

Management

As previously announced, Pedro Ros assumed the role of Chief Executive on 1 October 2014 having joined the Board on 14 July 2014.

Net Debt

The Group's cash position remains robust benefitting from strong operational cashflows. Net debt as at 30 September 2014 was £32.6m (30 September 2013: £39.2m).

 

Outlook

The overall trading background has not changed significantly since the full year 2014 results announcement and the business is on track to meet our expectations for the full year.

We are progressing well on our review of the businesses and expect to provide an update during December 2014.

 

 

-End-

 

 

 

For further information, please contact:

Wilmington Group plc

020 7422 6800

Pedro Ros, Chief Executive

Tony Foye, Chief Finance Officer

FTI Consulting

020 3727 1000

Charles Palmer / Emma Appleton

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGGRCGUPCGMA
Date   Source Headline
8th Jul 20193:54 pmRNSHolding(s) in Company
4th Jul 20197:00 amRNSExtension of debt facility
1st Jul 20195:11 pmRNSTotal Voting Rights
28th Jun 20197:00 amRNSWilmington plc Pre-close Trading Update
10th Jun 20194:41 pmRNSSecond Price Monitoring Extn
10th Jun 20194:35 pmRNSPrice Monitoring Extension
3rd Jun 20197:00 amRNSTotal Voting Rights
17th May 201912:13 pmRNSHolding(s) in Company
17th May 20199:21 amRNSHolding(s) in Company
16th May 20197:00 amRNSAppointment of Mark Milner as CEO
8th May 20197:00 amRNSChange of Company Secretary
3rd May 201911:18 amRNSDirector Declaration
1st May 20197:00 amRNSTotal Voting Rights
2nd Apr 20192:20 pmRNSTotal Voting Rights
1st Apr 20197:00 amRNSSAYE and Director/PDMR Shareholding
1st Mar 201911:00 amRNSHolding(s) in Company
1st Mar 201910:58 amRNSTotal Voting Rights
21st Feb 20197:00 amRNSResults for the six months ended 31 December 2018
14th Feb 201910:19 amRNSDirectorate Change Update
1st Feb 20193:53 pmRNSTotal Voting Rights
28th Jan 20194:44 pmRNSHolding(s) in Company
16th Jan 20197:00 amRNSDirectorate Change
2nd Jan 201910:33 amRNSTotal Voting Rights
14th Dec 20184:43 pmRNSNotification of Interim Results
3rd Dec 20187:00 amRNSTotal Voting Rights
14th Nov 20187:00 amRNSNew Joint Venture Agreement
1st Nov 20182:07 pmRNSResult of AGM
1st Nov 20187:00 amRNSTotal Voting Rights
1st Nov 20187:00 amRNSAGM Statement and Q1 Trading Update
17th Oct 20185:13 pmRNSHolding(s) in Company
1st Oct 20185:44 pmRNSDirector/PDMR Shareholding
1st Oct 201810:18 amRNSTotal Voting Rights
25th Sep 201812:29 pmRNSHolding(s) in Company
21st Sep 20183:13 pmRNSDirector/PDMR Shareholding
20th Sep 20183:19 pmRNSDirector/PDMR Shareholding
19th Sep 20182:12 pmRNSShare Awards
12th Sep 20187:00 amRNSFinancial results for the year ended 30 June 2018
3rd Sep 20189:00 amRNSTotal Voting Rights
28th Aug 201810:39 amRNSHolding(s) in Company
1st Aug 20189:00 amRNSTotal Voting Rights
19th Jul 20187:00 amRNSSale of ICP Credit Reporting Business
10th Jul 20184:24 pmRNSHolding(s) in Company
10th Jul 20184:19 pmRNSHolding(s) in Company
9th Jul 20182:23 pmRNSHolding(s) in Company
6th Jul 20187:00 amRNSTrading Statement
2nd Jul 201810:29 amRNSVoting Rights and Capital
1st Jun 20189:00 amRNSTotal Voting Rights
9th May 20187:00 amRNSCapital Markets Day
1st May 20187:00 amRNSTotal Voting Rights
3rd Apr 20187:00 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.